nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Leukopenia—Sorafenib—liver cancer	0.00342	0.00342	CcSEcCtD
Pamidronate—Bone pain—Epirubicin—liver cancer	0.00337	0.00337	CcSEcCtD
Pamidronate—Loss of consciousness—Sorafenib—liver cancer	0.00336	0.00336	CcSEcCtD
Pamidronate—Cough—Sorafenib—liver cancer	0.00334	0.00334	CcSEcCtD
Pamidronate—Inflammation—Epirubicin—liver cancer	0.00333	0.00333	CcSEcCtD
Pamidronate—Hypertension—Sorafenib—liver cancer	0.0033	0.0033	CcSEcCtD
Pamidronate—Arthropathy—Doxorubicin—liver cancer	0.00329	0.00329	CcSEcCtD
Pamidronate—Musculoskeletal pain—Epirubicin—liver cancer	0.00327	0.00327	CcSEcCtD
Pamidronate—Hypocalcaemia—Doxorubicin—liver cancer	0.00327	0.00327	CcSEcCtD
Pamidronate—Arthralgia—Sorafenib—liver cancer	0.00326	0.00326	CcSEcCtD
Pamidronate—Myalgia—Sorafenib—liver cancer	0.00326	0.00326	CcSEcCtD
Pamidronate—Herpes simplex—Doxorubicin—liver cancer	0.00325	0.00325	CcSEcCtD
Pamidronate—Hyperkalaemia—Epirubicin—liver cancer	0.00318	0.00318	CcSEcCtD
Pamidronate—Influenza like illness—Epirubicin—liver cancer	0.00314	0.00314	CcSEcCtD
Pamidronate—Bone pain—Doxorubicin—liver cancer	0.00312	0.00312	CcSEcCtD
Pamidronate—Anaphylactic shock—Sorafenib—liver cancer	0.00312	0.00312	CcSEcCtD
Pamidronate—Infection—Sorafenib—liver cancer	0.0031	0.0031	CcSEcCtD
Pamidronate—Candida infection—Epirubicin—liver cancer	0.00309	0.00309	CcSEcCtD
Pamidronate—Inflammation—Doxorubicin—liver cancer	0.00308	0.00308	CcSEcCtD
Pamidronate—Shock—Sorafenib—liver cancer	0.00307	0.00307	CcSEcCtD
Pamidronate—Nervous system disorder—Sorafenib—liver cancer	0.00306	0.00306	CcSEcCtD
Pamidronate—Thrombocytopenia—Sorafenib—liver cancer	0.00306	0.00306	CcSEcCtD
Pamidronate—Blood urea increased—Epirubicin—liver cancer	0.00305	0.00305	CcSEcCtD
Pamidronate—Musculoskeletal pain—Doxorubicin—liver cancer	0.00303	0.00303	CcSEcCtD
Pamidronate—Anorexia—Sorafenib—liver cancer	0.00297	0.00297	CcSEcCtD
Pamidronate—Hyperkalaemia—Doxorubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Pamidronate—Influenza like illness—Doxorubicin—liver cancer	0.0029	0.0029	CcSEcCtD
Pamidronate—Pulmonary oedema—Epirubicin—liver cancer	0.00288	0.00288	CcSEcCtD
Pamidronate—Candida infection—Doxorubicin—liver cancer	0.00286	0.00286	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00284	0.00284	CcSEcCtD
Pamidronate—Blood urea increased—Doxorubicin—liver cancer	0.00282	0.00282	CcSEcCtD
Pamidronate—Dyspnoea—Sorafenib—liver cancer	0.00278	0.00278	CcSEcCtD
Pamidronate—Dyspepsia—Sorafenib—liver cancer	0.00275	0.00275	CcSEcCtD
Pamidronate—Phlebitis—Epirubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Pamidronate—Decreased appetite—Sorafenib—liver cancer	0.00271	0.00271	CcSEcCtD
Pamidronate—Thrombophlebitis—Epirubicin—liver cancer	0.00271	0.00271	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Sorafenib—liver cancer	0.00269	0.00269	CcSEcCtD
Pamidronate—Fatigue—Sorafenib—liver cancer	0.00269	0.00269	CcSEcCtD
Pamidronate—Hepatic function abnormal—Epirubicin—liver cancer	0.00268	0.00268	CcSEcCtD
Pamidronate—Constipation—Sorafenib—liver cancer	0.00267	0.00267	CcSEcCtD
Pamidronate—Pain—Sorafenib—liver cancer	0.00267	0.00267	CcSEcCtD
Pamidronate—Pulmonary oedema—Doxorubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Pamidronate—Cardiac failure congestive—Epirubicin—liver cancer	0.00259	0.00259	CcSEcCtD
Pamidronate—Gastrointestinal pain—Sorafenib—liver cancer	0.00255	0.00255	CcSEcCtD
Pamidronate—Renal failure acute—Epirubicin—liver cancer	0.00254	0.00254	CcSEcCtD
Pamidronate—Phlebitis—Doxorubicin—liver cancer	0.00252	0.00252	CcSEcCtD
Pamidronate—Thrombophlebitis—Doxorubicin—liver cancer	0.00251	0.00251	CcSEcCtD
Pamidronate—Hepatic function abnormal—Doxorubicin—liver cancer	0.00248	0.00248	CcSEcCtD
Pamidronate—Abdominal pain—Sorafenib—liver cancer	0.00247	0.00247	CcSEcCtD
Pamidronate—Body temperature increased—Sorafenib—liver cancer	0.00247	0.00247	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Epirubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Pamidronate—Cardiac failure—Epirubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Pamidronate—Lethargy—Epirubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Pamidronate—Cardiac failure congestive—Doxorubicin—liver cancer	0.00239	0.00239	CcSEcCtD
Pamidronate—Renal failure acute—Doxorubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Pamidronate—Osteoarthritis—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Pamidronate—Hypersensitivity—Sorafenib—liver cancer	0.0023	0.0023	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00224	0.00224	CcSEcCtD
Pamidronate—Asthenia—Sorafenib—liver cancer	0.00224	0.00224	CcSEcCtD
Pamidronate—Cardiac failure—Doxorubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Pamidronate—Lethargy—Doxorubicin—liver cancer	0.00222	0.00222	CcSEcCtD
Pamidronate—Pruritus—Sorafenib—liver cancer	0.00221	0.00221	CcSEcCtD
Pamidronate—Blood creatinine increased—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Pamidronate—Osteoarthritis—Doxorubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Pamidronate—Liver function test abnormal—Epirubicin—liver cancer	0.00217	0.00217	CcSEcCtD
Pamidronate—Hypokalaemia—Epirubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Pamidronate—Diarrhoea—Sorafenib—liver cancer	0.00214	0.00214	CcSEcCtD
Pamidronate—Nasopharyngitis—Epirubicin—liver cancer	0.0021	0.0021	CcSEcCtD
Pamidronate—Gastritis—Epirubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Pamidronate—Dizziness—Sorafenib—liver cancer	0.00206	0.00206	CcSEcCtD
Pamidronate—Blood creatinine increased—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Pamidronate—Influenza—Epirubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—liver cancer	0.002	0.002	CcSEcCtD
Pamidronate—Vomiting—Sorafenib—liver cancer	0.00198	0.00198	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—liver cancer	0.00198	0.00198	CcSEcCtD
Pamidronate—Rash—Sorafenib—liver cancer	0.00197	0.00197	CcSEcCtD
Pamidronate—Dermatitis—Sorafenib—liver cancer	0.00197	0.00197	CcSEcCtD
Pamidronate—Headache—Sorafenib—liver cancer	0.00195	0.00195	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—liver cancer	0.00194	0.00194	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Pamidronate—Neutropenia—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Pamidronate—Nausea—Sorafenib—liver cancer	0.00185	0.00185	CcSEcCtD
Pamidronate—Pneumonia—Epirubicin—liver cancer	0.00182	0.00182	CcSEcCtD
Pamidronate—Infestation NOS—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Pamidronate—Infestation—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—liver cancer	0.00178	0.00178	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—liver cancer	0.00172	0.00172	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—liver cancer	0.00164	0.00164	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—liver cancer	0.00162	0.00162	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—liver cancer	0.0016	0.0016	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—liver cancer	0.00159	0.00159	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—liver cancer	0.00157	0.00157	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Pamidronate—Flushing—Epirubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—liver cancer	0.00151	0.00151	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—liver cancer	0.00148	0.00148	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—liver cancer	0.00147	0.00147	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Pamidronate—Chills—Epirubicin—liver cancer	0.00146	0.00146	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—liver cancer	0.00143	0.00143	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Pamidronate—Erythema—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Pamidronate—Tension—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Pamidronate—Back pain—Epirubicin—liver cancer	0.00137	0.00137	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—liver cancer	0.00136	0.00136	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Pamidronate—Chills—Doxorubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—liver cancer	0.00131	0.00131	CcSEcCtD
Pamidronate—Agitation—Epirubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Pamidronate—Tension—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—liver cancer	0.00128	0.00128	CcSEcCtD
Pamidronate—Malaise—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Pamidronate—Syncope—Epirubicin—liver cancer	0.00127	0.00127	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—liver cancer	0.00124	0.00124	CcSEcCtD
Pamidronate—Cough—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—liver cancer	0.00122	0.00122	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—liver cancer	0.00121	0.00121	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—liver cancer	0.0012	0.0012	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—liver cancer	0.00119	0.00119	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—liver cancer	0.00117	0.00117	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Pamidronate—Oedema—Epirubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Pamidronate—Infection—Epirubicin—liver cancer	0.00115	0.00115	CcSEcCtD
Pamidronate—Cough—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Pamidronate—Shock—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—liver cancer	0.00113	0.00113	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—liver cancer	0.0011	0.0011	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—liver cancer	0.00108	0.00108	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—liver cancer	0.00107	0.00107	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—liver cancer	0.00107	0.00107	CcSEcCtD
Pamidronate—Infection—Doxorubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Pamidronate—Shock—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—liver cancer	0.00105	0.00105	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—liver cancer	0.00104	0.00104	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—liver cancer	0.00102	0.00102	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—liver cancer	0.001	0.001	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—liver cancer	0.000997	0.000997	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000996	0.000996	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—liver cancer	0.000994	0.000994	CcSEcCtD
Pamidronate—Pain—Epirubicin—liver cancer	0.000986	0.000986	CcSEcCtD
Pamidronate—Constipation—Epirubicin—liver cancer	0.000986	0.000986	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000972	0.000972	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—liver cancer	0.000965	0.000965	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—liver cancer	0.000958	0.000958	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—liver cancer	0.000951	0.000951	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—liver cancer	0.00095	0.00095	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—liver cancer	0.000949	0.000949	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—liver cancer	0.000943	0.000943	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—liver cancer	0.000939	0.000939	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—liver cancer	0.000928	0.000928	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000921	0.000921	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—liver cancer	0.00092	0.00092	CcSEcCtD
Pamidronate—Pain—Doxorubicin—liver cancer	0.000913	0.000913	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—liver cancer	0.000913	0.000913	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—liver cancer	0.000912	0.000912	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—liver cancer	0.000912	0.000912	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—liver cancer	0.000879	0.000879	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000873	0.000873	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—liver cancer	0.00085	0.00085	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—liver cancer	0.000844	0.000844	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—liver cancer	0.000844	0.000844	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—liver cancer	0.000827	0.000827	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—liver cancer	0.000816	0.000816	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—liver cancer	0.000789	0.000789	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—liver cancer	0.000786	0.000786	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—liver cancer	0.000766	0.000766	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—liver cancer	0.000763	0.000763	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—liver cancer	0.000755	0.000755	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—liver cancer	0.000733	0.000733	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—liver cancer	0.00073	0.00073	CcSEcCtD
Pamidronate—Rash—Epirubicin—liver cancer	0.000727	0.000727	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—liver cancer	0.000726	0.000726	CcSEcCtD
Pamidronate—Headache—Epirubicin—liver cancer	0.000722	0.000722	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—liver cancer	0.000706	0.000706	CcSEcCtD
Pamidronate—Nausea—Epirubicin—liver cancer	0.000685	0.000685	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—liver cancer	0.000678	0.000678	CcSEcCtD
Pamidronate—Rash—Doxorubicin—liver cancer	0.000673	0.000673	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—liver cancer	0.000672	0.000672	CcSEcCtD
Pamidronate—Headache—Doxorubicin—liver cancer	0.000669	0.000669	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—liver cancer	0.000634	0.000634	CcSEcCtD
